ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,184.97
-0.05%
Dow Jones
39,026.38
0.37%
US Dollar vs MXN
16.9034
-0.02%
Brent Oil
83.505
0.77%
Bitcoin
62,451.85
0.19%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Titan Pharmaceuticals Inc (TTNP)

  7. Titan Pharmaceuticals Inc (TTNP) Noticias

TTNP

Titan Pharmaceuticals (TTNP)

Titan Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TTNP
FechaHoraFuenteTítuloSímboloCompañía
25/01/202415:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTNPTitan Pharmaceuticals Inc
25/01/202415:29GlobeNewswire Inc.Titan Pharmaceuticals Fully Compliant With NASDAQ Listing CriteriaNASDAQ:TTNPTitan Pharmaceuticals Inc
28/12/202315:15GlobeNewswire Inc.Titan Pharmaceuticals Announces Reverse Stock Split and RatioNASDAQ:TTNPTitan Pharmaceuticals Inc
28/11/202315:47Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
17/11/202315:03Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTNPTitan Pharmaceuticals Inc
26/10/202315:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
24/10/202316:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TTNPTitan Pharmaceuticals Inc
23/10/202314:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TTNPTitan Pharmaceuticals Inc
16/10/202315:37GlobeNewswire Inc.Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of DirectorsNASDAQ:TTNPTitan Pharmaceuticals Inc
04/10/202316:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TTNPTitan Pharmaceuticals Inc
19/09/202315:41Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
18/09/202306:30GlobeNewswire Inc.Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred StockNASDAQ:TTNPTitan Pharmaceuticals Inc
14/08/202316:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TTNPTitan Pharmaceuticals Inc
31/07/202318:45Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TTNPTitan Pharmaceuticals Inc
27/07/202306:30GlobeNewswire Inc.Titan Pharmaceuticals Announces Sale of Certain ProNeura AssetsNASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202315:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TTNPTitan Pharmaceuticals Inc
23/06/202315:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202308:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
19/05/202308:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/05/202315:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/04/202315:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
31/03/202315:36Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TTNPTitan Pharmaceuticals Inc
15/12/202206:00GlobeNewswire Inc.Titan Pharmaceuticals Provides Shareholder UpdateNASDAQ:TTNPTitan Pharmaceuticals Inc
12/12/202206:49GlobeNewswire Inc.UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.NASDAQ:TTNPTitan Pharmaceuticals Inc
30/08/202215:03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TTNPTitan Pharmaceuticals Inc
16/08/202209:53PR Newswire (US)Titan Pharmaceuticals Announces Board Expansion and Management ChangesNASDAQ:TTNPTitan Pharmaceuticals Inc
25/07/202213:05Edgar (US Regulatory)Proxy Statement - Non-management (definitive) (defn14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
14/07/202211:48Edgar (US Regulatory)Proxy Statements Not Involving Contested Solicitations (preliminary) (pren14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202215:00Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:TTNPTitan Pharmaceuticals Inc
11/07/202207:00GlobeNewswire Inc.Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of StockholdersNASDAQ:TTNPTitan Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TTNP

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
USI
USTECH100
US Tech 100
FX
EURUSD
Euro vs US Dollar
NYSE
AXP
American Express
USOTC
BASFY
BASF (QX)
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
USOTC
BNPQY
BNP Paribas (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
CVX
Chevron
NYSE
MRK
Merck
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados